C8orf82: A Potential Drug Target and Biomarker for Chromosome 8 Open Reading Frame 82

Target Name: C8orf82

NCBI ID: G414919

C8orf82

Other Name(s): chromosome 8 open reading frame 82 | Chromosome 8 open reading frame 82 | UPF0598 protein C8orf82 | CH082_HUMAN

C8orf82: A Potential Drug Target and Biomarker for Chromosome 8 Open Reading Frame 82

Chromosome 8 (C8) is one of the human chromosomes that encodes a large gene cluster, including proteins involved in various cellular processes, such as growth, development, and disease. Chromosome 8 open reading frame 82 (C8ORF82) is a gene located on chromosome 8 that has been identified as a potential drug target and biomarker. This article will discuss the C8ORF82 gene, its function, potential drug targets, and potential clinical applications.

Function and Expression

C8ORF82 is a gene that encodes a protein named C8ORF82, which is a 22-kDa protein that contains 11 unique amino acid residues. The protein is expressed in various tissues and cells of the body and is involved in various cellular processes, including cell adhesion, migration, and invasion.

Potential Drug Targets

C8ORF82 has been identified as a potential drug target due to its unique structure and various cellular processes involved in its function. One of the potential drug targets for C8ORF82 is the interaction between C8ORF82 and the protein known as PDGF-BB, which is a potent regulator of cell growth and differentiation.

The interaction between C8ORF82 and PDGF-BB has been shown to play a role in various cellular processes, including the regulation of cell proliferation, migration, and invasion. Additionally, the interaction between C8ORF82 and PDGF-BB has been linked to the development of various diseases, including cancer.

Another potential drug target for C8ORF82 is its role in the regulation of cell adhesion and migration. C8ORF82 has been shown to play a role in the regulation of cell adhesion and has been linked to the development of various diseases, including cancer.

Potential Biomarkers

C8ORF82 has also been identified as a potential biomarker for various diseases, including cancer. The expression of C8ORF82 has been shown to be affected by various cellular processes, including the regulation of cell growth and differentiation.

Clinical Applications

The potential drug targets and biomarkers for C8ORF82 have significant implications for the development of new therapies for various diseases, including cancer. One of the potential drug targets for C8ORF82 is the interaction between C8ORF82 and PDGF-BB, which has been shown to play a role in the regulation of cell growth and differentiation.

Additionally, C8ORF82 has been shown to play a role in the regulation of cell adhesion and migration, which has been linked to the development of various diseases, including cancer. Therefore, C8ORF82 may be a useful biomarker for the diagnosis and treatment of various diseases, including cancer.

Conclusion

C8ORF82 is a gene that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and various cellular processes involved in its function make it an attractive target for the development of new therapies. Further research is needed to fully understand the function and potential clinical applications of C8ORF82.

Protein Name: Chromosome 8 Open Reading Frame 82

The "C8orf82 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C8orf82 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets